BSE Live
Jan 19, 14:54Prev. Close
860.00
Open Price
860.05
Bid Price (Qty.)
857.75 (1)
Offer Price (Qty.)
858.35 (123)
NSE Live
Jan 19, 14:54Prev. Close
859.40
Open Price
861.00
Bid Price (Qty.)
857.55 (50)
Offer Price (Qty.)
858.00 (15)
| Key Financial Ratios of Natco Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 46.17 | 34.49 | 25.02 | 21.39 | 18.52 | |
| Diluted EPS (Rs.) | 46.17 | 34.49 | 24.91 | 21.39 | 18.52 | |
| Cash EPS (Rs.) | 58.79 | 41.42 | 31.23 | 24.89 | 23.61 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 264.48 | 221.60 | 171.35 | 150.08 | 123.24 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 264.48 | 221.60 | 171.35 | 150.08 | 123.24 | |
| Dividend / Share(Rs.) | 5.00 | 5.00 | 4.00 | 3.00 | 2.00 | |
| Revenue from Operations/Share (Rs.) | 215.30 | 188.17 | 177.81 | 138.69 | 123.76 | |
| PBDIT/Share (Rs.) | 72.85 | 61.16 | 53.83 | 38.81 | 32.87 | |
| PBIT/Share (Rs.) | 60.08 | 53.07 | 47.50 | 33.86 | 27.78 | |
| PBT/Share (Rs.) | 46.46 | 42.77 | 35.80 | 26.49 | 22.73 | |
| Net Profit/Share (Rs.) | 46.01 | 33.32 | 24.91 | 19.95 | 18.52 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 33.83 | 32.50 | 30.27 | 27.98 | 26.56 | |
| PBIT Margin (%) | 27.90 | 28.20 | 26.71 | 24.41 | 22.44 | |
| PBT Margin (%) | 21.57 | 22.72 | 20.13 | 19.10 | 18.36 | |
| Net Profit Margin (%) | 21.37 | 17.70 | 14.00 | 14.38 | 14.96 | |
| Return on Networth / Equity (%) | 17.39 | 15.03 | 14.53 | 13.29 | 15.02 | |
| Return on Capital Employed (%) | 15.34 | 12.50 | 10.78 | 9.68 | 10.27 | |
| Return on Assets (%) | 10.96 | 9.36 | 7.38 | 6.98 | 7.48 | |
| Total Debt/Equity (X) | 0.30 | 0.26 | 0.53 | 0.46 | 0.57 | |
| Asset Turnover Ratio (%) | 51.29 | 52.91 | 52.75 | 48.58 | 50.04 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.12 | 1.14 | 0.93 | 1.19 | 1.24 | |
| Quick Ratio (X) | 0.62 | 0.60 | 0.55 | 0.79 | 0.74 | |
| Inventory Turnover Ratio (X) | 3.61 | 3.84 | 4.35 | 4.44 | 3.74 | |
| Dividend Payout Ratio (NP) (%) | 10.86 | 15.00 | 16.05 | 15.04 | 10.80 | |
| Dividend Payout Ratio (CP) (%) | 8.50 | 12.07 | 12.80 | 12.05 | 8.46 | |
| Earnings Retention Ratio (%) | 89.14 | 85.00 | 83.95 | 84.96 | 89.20 | |
| Cash Earnings Retention Ratio (%) | 91.50 | 87.93 | 87.20 | 87.95 | 91.54 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 7,270.36 | 2,821.83 | 1,621.56 | 1,283.90 | 936.19 | |
| EV/Net Operating Revenue (X) | 10.16 | 4.53 | 2.91 | 2.97 | 2.69 | |
| EV/EBITDA (X) | 30.03 | 13.95 | 9.60 | 10.62 | 10.12 | |
| MarketCap/Net Operating Revenue (X) | 9.80 | 4.24 | 2.41 | 2.55 | 2.21 | |
| Retention Ratios (%) | 89.13 | 84.99 | 83.94 | 84.95 | 89.19 | |
| Price/BV (X) | 7.98 | 3.60 | 2.50 | 2.36 | 2.22 | |
| Price/Net Operating Revenue | 9.80 | 4.24 | 2.41 | 2.55 | 2.21 | |
| Earnings Yield | 0.02 | 0.04 | 0.06 | 0.06 | 0.07 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y